Division 5.1.7 F1F2 United Kingdom Original text. Later amendments are not shown. A strategy for the long-term follow-up of safety and efficacy shall be included in the risk management plan. Annotations Textual amendments F1 Substituted by Commission directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (Text with EEA relevance). F2 Substituted by Commission Directive 2009/120/EC of 14 September 2009 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use as regards advanced therapy medicinal products (Text with EEA relevance). ← Division 5.1.6 Division 5.1.7 Division 5.1.8 →